Actually I hope you're right and IPCI somehow incorporates the January and February Focalin Sales in the 1st quarter reporting... as this would make it more apparent that there is likely no need to raise money in the near future or ever again for that matter.
I think it's imperative now to make it crystal clear that there is no further dilution required to a hostile poison financeeer.
I believe you don't short 1.8 million shares without thinking you can get that quantity stock from the company when they reach out to do a fund raiser... I think it's important right now for IPCI to shout out %$&8 @#+... we've got enough not to ever dilute again!!!
I think securing a partner for Glucophage where they receive ~ $1 million upfront milestone payment... even if it means accepting a smaller % royalty would go a long way to causing a panic in the shorts camp.
ps: More than likely whoever partners Rexista and/or Regabatin will want a stake in IPCI... I'm assuming around 3 million shares... but I don't consider that a negative.